Octapharma

About one in four women experience heavy menstrual bleeding throughout their lives. Some may become desensitised to heavy menstrual bleeding, or think it's normal and might be reluctant to discuss it with their doctor. Heavy menstrual bleeding is a warning sign for von Willebrand disease (VWD), the most common congential bleeding disoder in the world. If you are worried, visit vwdtest.com for information about abnormal bleeding and take a simple online test to see if your bleeding symptoms merit further investigation. #BleedingDisordersAwarenessMonth #vonwillebranddisease #VWD

Next week at #ISICEM25 we bring together experts to explore the evolving landscape of surgical bleeding management and its impact on clinical practice. Join us on Tuesday, March 18 at 12:30 live in Brussels or virtually on Science Hub! See the details here: https://bit.ly/4hxDNE8 The event is for healthcare professionals only. #criticalcare #emergencymedicine #bleedingmanagement

We are looking for a Group HRIS Expert to join our team in Lachen, Switzerland! As a Group HRIS Expert, you will manage and optimize the SAP SuccessFactors system and collaborate with HR, IT, and other departments to ensure the system meets organisational needs. You will lead HRIS projects, drive the implementation of HR systems, and provide training and guidance. Learn more about this opportunity and apply: https://bit.ly/4kEHBpQ

NHS patients are now receiving medicines made from UK-donated plasma for the first time in almost three decades. This is a significant milestone for the UK! We are proud of this unique partnership with the Department of Health and Social Care, NHS England, NHS Blood and Transplant, and our role as the sole manufacturer for the UK Plasma for Medicines (PfM) Programme. Learn more here: https://bit.ly/3F5SMrF #UKPlasmaMedicines Photo credit: Oxford Medical Illustration (OMI), Oxford University Hospitals.

International Women's Day, celebrated on March 8, is a global opportunity to recognise the many and varied contributions of women across all fields. It serves as an annual reminder that women have made groundbreaking discoveries and achievements in numerous areas, including science, that have shaped our world. To celebrate International Women’s Day this year, we interviewed two colleagues, Johanna Fridheim and Nadezhda Lagoiko to explore how an inclusive environment that values unique and curious minds can inspire us all to innovate every day. Read their responses here: https://bit.ly/3DoZs3w

For the first time in almost 30 years, NHS patients are receiving medicines made using UK-donated plasma.   As the sole manufacturer of these plasma-derived medicines for the Plasma for Medicines (PfM) programme, this is a major milestone for us and our partners at the Department of Health and Social Care (DHSC), NHS England (NHSE), and NHS Blood and Transplant (NHSBT).   The medicines we produce are relied on every day by thousands of UK patients with chronic diseases and immune deficiencies and are also used in emergencies for the critically ill following trauma, burns or surgery.   This unique partnership is building a more resilient supply chain for patients nationwide, reducing the country’s reliance on medicines made using imported plasma. Learn more here: https://bit.ly/3F5SMrF   #UKPlasmaMedicines

As healthcare goes increasingly digital, mobile health apps are transforming patient care through real-time treatment monitoring and personalized support. These tools help patients stay engaged with their health, adhere to treatment plans, and communicate with their care teams. Discover flexIG, a digital therapy diary crafted to simplify subcutaneous immunoglobulin (SCIg) therapy. With features like treatment reminders, injection tracking, and easy report sharing with healthcare providers, flexIG empowers patients to take control of their health and improve treatment outcomes. Learn more about how flexIG is advancing patient care: https://bit.ly/41rDFjy

Magda was diagnosed with non-Hodgkin Burkitt lymphoma at the age of 12. Over time, as her immune system was already compromised by cancer, she developed secondary immunodeficiency (#SID), a rare condition in which the immune system struggles to function properly following illness or treatment. For Magda, SID led to frequent infections and respiratory issues. Finding the right treatment allowed Magda to take control of her health, giving her freedom to focus on her studies and enjoy life. To mark Rare Disease Day on February 28, we share her story. Awareness is key to earlier diagnosis, more effective treatment, and improved quality of life for patients suffering from rare diseases. Read the full story here: https://bit.ly/3Qy33PM #RareDiseaseDay

Join our team as a Group Manager Environmental Sustainability in Lachen, Switzerland! In this role, you will develop and implement a comprehensive environmental sustainability strategy, drive initiatives to reduce GHG emissions, energy consumption, and water usage, and calculate corporate and product carbon footprints. You will collaborate with internal teams to integrate sustainable practices, track key performance indicators, and contribute to the Group CSRD Sustainability Statement. Are you ready to make a difference? Apply now: https://bit.ly/41jEjzw

We are looking for a Group Expert Total Rewards to join our team in Dessau, Langenfeld, or Springe! As a Group Expert Total Rewards, you will partner with HR, finance, and other stakeholders to guide compensation and benefits for our sites in Germany. You will collaborate with the Group Total Rewards team to align with global strategies, develop and execute compensation and benefits plans, and manage job evaluations, salary benchmarking, and annual reviews. Additionally, you will oversee employee benefit programs and incentive schemes, ensuring compliance with local labor laws. Read more about this opportunity and apply: https://bit.ly/415keNy